February 14, 2014
Drug manufacturers have a responsibility to ensure their products are safe. Failure to do so can result in costly penalties and civil litigation being filed against the responsible parties.
One such case stems from the thousands of steroid injections distributed by a Massachusetts compounding center that contained a fungus which sickened hundreds and claimed the lives of 16 Tennesseans.
Now, thousands of claims are being filed against the compounding center responsible for the Fungal Meningitis Outbreak. Included in those lawsuits is one filed by Saint Thomas Outpatient Neurosurgical Center for $1.17 billion. An article from The Tennessean stated the Specialty Surgery Center of Crossville has filed a similar claim for $240 million, while an affiliate with the facility is seeking an additional $25 million. Experts say $100 million may be all that is available to the victims of the outbreak, however.
The claims were filed in U.S. Bankruptcy Court in Boston, and the first trials in the case are expected to begin in the coming months.
The Nashville Personal Injury Lawyers with Ponce Law are aware of how difficult recovering from drug injuries can be. That is why the firm is hopeful a resolution to these cases brings a sense of closure to the victims of the outbreak and their families.
